10/8/2008

RiskMetrics Group and two other advisory firms urged shareholders of Applied Biosystems and Invitrogen to support a $6.4 billion merger of the companies, which both make medical-research tools. The companies scheduled separate meetings for stockholders to decide whether to approve the deal.

Related Summaries